APERTURE Venture Partners — 2011 Investments
2 investments dated 2011 · listed companies and verified rows first · show all
Avedro is an ophthalmic company focused on corneal health, known for bio-activated cross-linking therapies such as the KXL system and riboflavin-based treatments used to address progressive keratoconus.
BiotechHealthtechMedical DevicesWaltham, US
David F. Muller(Executive Officer, Director)inBrian J. Roberts(Executive Officer)inRhonda J. Bracey(Executive Officer)inThomas W. Burns(Chairman & Chief Executive Officer)
BoardJason Hong(Director)Jeff Dykan(Director)in
Co-investorsLAVLilly Asia VenturesSCP Vitalife PartnersThird Point VenturesWestern Technology InvestmentAbingworth+5 more
HealthtechMountain View, US
Kenneth Binmoeller, M.D.(Executive Officer, Director)inGreg Patterson(Executive Officer, Director)
BoardA. Barr Dolan(Director)Eric Sillman(Director)Anthony Natale, M.D.(Director)Avi Kometz(Director)
Co-investorsATEL VenturesThird Point VenturesAscent Biomedical VenturesDeerfield Management CompanyThird PointWestern Technology Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







